Guan Zheng-Bing, Cao Peng, Ye Ji-Lin, Zhang Shuang-Quan
Jiangsu Province Key Laboratoryfor Molecular and Medical Biotechnology, Life Sciences College, Nanjing Normal University, Nanjing 210097, China.
Sheng Wu Gong Cheng Xue Bao. 2006 Jan;22(1):46-51.
BCMA is one of the transmembrane receptors belonging to BAFF and APRIL. In order to identify the feasibility of sBCMA as decoy receptor and obtain active sBCMA for its structural and functional research, full length of hBCMA was amplified with total RNA from Raji cell line by RT-PCR, and the cDNA encoding the extracelluar soluble domain of hBCMA was inserted into pET43.1a(+) vector. The recombinant vector pET43.1a(+)-sBCMA was transformed into E. coli Origami B(DE3) pLyS which is helpful for disulfide bond construction of expression proteins. After IPTG induction, the recombinant protein was expressed as soluble fusion protein, sBCMA-NusA-His6, and identified by western blotting. Then the target protein was purified by Ni(+)-chelating Sepharose Fast Flow. The binding activity between recombinant sBCMA and BAFF was detected by ELISA. Also, Recombinant sBCMA inhibited proliferation of mouse B cell stimulating by rhsBAFF. It was proved that recombinant sBCMA has good bioactivity and the method to express those proteins rich in disulfide bond is feasible and effectual.
BCMA是属于BAFF和APRIL的跨膜受体之一。为了确定可溶性BCMA(sBCMA)作为诱饵受体的可行性,并获得具有活性的sBCMA用于其结构和功能研究,通过RT-PCR从Raji细胞系的总RNA中扩增出人BCMA(hBCMA)全长,并将编码hBCMA细胞外可溶性结构域的cDNA插入pET43.1a(+)载体。将重组载体pET43.1a(+)-sBCMA转化到有助于表达蛋白二硫键构建的大肠杆菌Origami B(DE3) pLyS中。经IPTG诱导后,重组蛋白以可溶性融合蛋白sBCMA-NusA-His6的形式表达,并通过蛋白质免疫印迹法进行鉴定。然后通过Ni(+)-螯合琼脂糖凝胶快速流速柱纯化目标蛋白。通过酶联免疫吸附测定法检测重组sBCMA与BAFF之间的结合活性。此外,重组sBCMA抑制了重组人BAFF(rhsBAFF)刺激的小鼠B细胞增殖。证明重组sBCMA具有良好的生物活性,且表达富含二硫键蛋白的方法是可行且有效的。